These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Matching models to data: a receptor pharmacologist's guide. Hall DA; Langmead CJ Br J Pharmacol; 2010 Nov; 161(6):1276-90. PubMed ID: 20977467 [TBL] [Abstract][Full Text] [Related]
24. The placebo effect. Watson R J Clin Nurs; 2006 May; 15(5):519. PubMed ID: 16629958 [No Abstract] [Full Text] [Related]
25. [Pharmacology and pharmacotherapy in Japan]. Van Zwieten PA Ned Tijdschr Geneeskd; 1990 Mar; 134(11):549-50. PubMed ID: 2320149 [No Abstract] [Full Text] [Related]
26. Clinical pharmacology, looking ahead into the future. Wang RI J Clin Pharmacol; 1978 Oct; 18(10):443-7. PubMed ID: 361763 [No Abstract] [Full Text] [Related]
27. Methodological changes in the evaluation of complementary and alternative medicine: issues raised by Sherman et al. and Hawk et al. Redwood D J Altern Complement Med; 2002 Feb; 8(1):5-6. PubMed ID: 11890434 [No Abstract] [Full Text] [Related]
28. The proper role of evidence in complementary/alternative medicine. Hansen K; Kappel K J Med Philos; 2010 Feb; 35(1):7-18. PubMed ID: 20026527 [TBL] [Abstract][Full Text] [Related]
29. Complementary and alternative medical treatments: can they really be evaluated by randomised controlled trials? Wan L Acupunct Med; 2016 Oct; 34(5):410-411. PubMed ID: 27586665 [No Abstract] [Full Text] [Related]
30. Randomized controlled trials: the control group dilemma revisited. Hart A Complement Ther Med; 2001 Mar; 9(1):40-4. PubMed ID: 11264969 [TBL] [Abstract][Full Text] [Related]
32. Data and evidence: there is a difference! (a commentary and debate on Healy et al.). Edwards R Int J Risk Saf Med; 2013; 25(2):123-9. PubMed ID: 23796471 [No Abstract] [Full Text] [Related]
33. Clinical recommendations of Cochrane reviews in three different fields of pediatrics (neonatology, neuropediatrics, and complementary and alternative medicine): a systematic analysis. Meyer S; Schroeder N; Willhelm C; Gortner L; Girisch W Pediatr Int; 2013 Jun; 55(3):396-8. PubMed ID: 23566199 [No Abstract] [Full Text] [Related]
35. The thorny path of clinical pharmacology. Gross F Clin Pharmacol Ther; 1978 Oct; 24(4):383-94. PubMed ID: 688729 [No Abstract] [Full Text] [Related]
36. The role of complementary and alternative medicine. Ernst E BMJ; 2000 Nov; 321(7269):1133-5. PubMed ID: 11061738 [No Abstract] [Full Text] [Related]
38. Sponsorship bias and quality of randomised controlled trials in veterinary medicine. Wareham KJ; Hyde RM; Grindlay D; Brennan ML; Dean RS BMC Vet Res; 2017 Aug; 13(1):234. PubMed ID: 28807033 [TBL] [Abstract][Full Text] [Related]
39. For randomized controlled trials, the quality of reports of complementary and alternative medicine was as good as reports of conventional medicine. Klassen TP; Pham B; Lawson ML; Moher D J Clin Epidemiol; 2005 Aug; 58(8):763-8. PubMed ID: 16018911 [TBL] [Abstract][Full Text] [Related]
40. AHI perspectives: flexible drug labeling and its impact on the drug development process. A clinical pharmacologist's perspective. Ter Hune TN J Am Vet Med Assoc; 1995 Oct; 207(7):898; discussion 902-4. PubMed ID: 7559020 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]